Perturbation-based Non-perturbative Method

This paper presents a non-perturbative method for solving eigenproblems. This method applies to almost all potentials and provides non-perturbative approximations for any energy level. The method converts an eigenproblem into a perturbation problem, obtains perturbation solutions through standard perturbation theory, and then analytically continues the perturbative solution into a non-perturbative solution

Optimized antimicrobial and antiproliferative activities of titanate nanofibers containing silver

Titanate nanofibers containing silver have been demonstrated through the experiments reported herein to have effective antifungal and antiproliferative activities in the presence of UV light. The titanate nanofibers containing silver can be fabricated by means of ion exchange followed by a topochemical process in an environment suitable for reductive reactions. Excellent antibacterial, antifungal, and antiproliferative activities could be demonstrated by both Ag2Ti5O11 · xH2O and Ag/titanate (UV light irradiation) due to their unique structures and compositions, which have photocatalytic activities to generate reactive oxygen species and capabilities to continuously release the silver ions. Therefore these materials have the potential to produce a membrane for the treatment of superficial malignant tumor, esophageal cancer, or cervical carcinoma. They may also hold utility if incorporated into a coating on stents in moderate and advanced stage esophageal carcinoma or for endoscopic retrograde biliary drainage. These approaches may significantly reduce infections, inhibit tumor growth, and importantly, improve quality of life and prolong survival time for patients with tumors

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin:A Study from the Chinese Atrial Fibrillation Registry

Background: Several factors determine the efficacy of warfarin anticoagulation in patients with non-valvular atrial fibrillation (NVAF). This study aimed to use data from the Chinese Atrial Fibrillation Registry study to assess the control of anticoagulation therapy in Chinese patients with NVAF treated with warfarin. Material/Methods: From the Chinese Atrial Fibrillation Registry study the anticoagulant use and dosing, the time in therapeutic range (TTR) of the international normalized ratio (INR), and standard deviation of the observed INR values (SD INR), and their influencing factors were evaluated. Results: The median INR and SD INR were 2.04 (IQR 1.71–2.41) and 0.50 (IQR, 0.35–0.69), respectively. The median TTR was 51.7% (IQR, 30.6–70.1%) and only 25.1% had a TTR ≥70%. Age was ≥70 years (OR, 0.72; 95% CI, 0.55–0.94; P=0.015), bleeding history (OR 0.48; 95% CI, 0.23–0.89; P=0.029), the use of a single drug (OR, 0.62; 95% CI, 0.42–0.92; P=0.016), more than drug (OR, 0.60; 95% CI, 0.41–0.88; P=0.009), and lack of assessment of bleeding risk (OR, 0.72; 95% CI, 0.54–0.97; P=0.033) were associated with TTR &lt;70% (INR 2.0–3.0). Coronary heart disease (CHD) and peripheral artery disease (PAD) (OR, 0.69; 95% CI, 0.52–0.90; P=0.007) and diabetes mellitus (OR, 0.79; 95% CI, 0.62–0.99; P=0.044) were associated with increased variability in INR (SD INR ≥0.5). Conclusions: In Chinese patients with NVAF, warfarin anticoagulation was associated with lower TTR and less stable anticoagulation than in current guidelines, and risk factors for reduced safety and efficacy were identified. </p

Magnesium Lithospermate B Protects Cardiomyocytes from Ischemic Injury Via Inhibition of TAB1–p38 Apoptosis Signaling

Danshen has been used in traditional Chinese medicine for hundreds of years to treat cardiovascular diseases. However, its precise cardioprotective components and the underlying mechanism are still unclear. In the present study, we demonstrated that in a rat model of acute myocardial infarction, the treatment with magnesium lithospermate B (MLB), the representative component of phenolic acids in Danshen, significantly reduced the infarct size and the blood lactate dehydrogenase level. In contrast, tanshinone IIA, the representative component of lipophilic tanshinones in Danshen, had no such protective effects. Moreover, in the simulated ischemia cell model, MLB treatment considerably increased the cell viability and reduced the sub-G1 population and the apoptotic nuclei, indicating its anti-apoptotic effect. Further mechanism study revealed that the ischemia-induced p38 phosphorylation was abolished by MLB treatment. Interestingly, MLB specifically inhibited the TGFβ-activated protein kinase 1-binding protein 1 (TAB1) mediated p38 phosphorylation through disrupting the interaction between TAB1 and p38, but it did not affect the mitogen-activated protein kinase 3/6 mediated p38 phosphorylation. In conclusion, the present study identifies MLB as an active component of Danshen in protecting cardiomyocytes from ischemic injury through specific inhibition of TAB1–p38 apoptosis signaling. These results indicate TAB1–p38 interaction as a putative drug target in treating ischemic heart diseases

Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry

Background: "Atrial fibrillation Better Care" (ABC) pathway has been proposed to improve the management of patients suffered from atrial fibrillation (AF). This integrated or holistic management approach comprise of three aspects, including "A" Avoid stroke or Anticoagulation; "B" Better symptom control with rate or rhythm control strategies; "C" Cardiovascular risk factor and Concomitant diseases management. We aimed to confirm the beneficial evidence of ABC pathway compliance in a Chinese AF cohort. Method and Results: From the Chinese Atrial Fibrillation registry (CAFR) dataset, a total of 19,187 non-valvular AF patients were enrolled, of which 4.365 (22.8%) were ABC pathway compliant (ABC compliance group). During a median follow-up of 4.1 ± 1.8 years, The incident rate of all-cause death in ABC compliance group and non-ABC compliance group is 2.7 and 1.1 per 100 person-year (p p p Conclusion: In a large cohort of Chinese AF patients, ABC pathway compliance shows an independently association with reduction of all-cause death and composite outcome of all-cause death, ischemic stroke and intracranial hemorrhage. Better compliance of ABC integrated care contributes to lower HR for adverse events

Branching ratios and CP-violating asymmetries of Bs→h1h2B_s \to h_1 h_2 decays in the general two-Higgs doublet models

Based on the low-energy effective Hamiltonian with the generalized factorization, we calculate the new physics contributions to branching ratios and CP-violating asymmetries of the charmless hadronic decays $B_s \to h_1 h_2$ in the standard model and the general two-Higgs doublet models (models I, II, and III). Within the considered paramter space, we find the following. (a) In models I and II, the new physics corrections are always small in size and will be masked by other larger known theoretical uncertainties. (b) In model III, the new physics corrections to the branching ratios of those QCD penguin-dominated decays \ov B_s \to K^0\etapp, K^+ K^{-*}, etc., are large in size and insensitive to the variations of \mhp and \nceff. For tree- or electroweak penguin-dominated decay modes, however, the new physics corrections are very small in size. (c) For \ov B_s \to K^+ K^{-*} and other seven decay modes, the branching ratios are at the level of $(1-3)\times 10^{-5}$ and will be measurable at the future hadron colliders with large $b$ production. (d) Among the studied thirty nine $B_s$ meson decay modes, seven of them can have a CP-violating asymmetry ${\cal A}_{CP}$ larger than 20% in magnitude. The new physics corrections are small or moderate in magnitude. (e) Because of its large and \nceff stable branching ratio and CP violating asymmetry, the decay \ov B_s \to K^+ K^{-*} seems to be the "best" channel to find CP violation of $B_s$ system through studies of two-body charmless decays of $B_s$ meson.Comment: 39 pages, Revtex, 9 eps figures, final version accepted for publication in Phys.Rev.